4//SEC Filing
Levine James E. 4
Accession 0001209191-20-020747
CIK 0001610618other
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 7:16 PM ET
Size
7.5 KB
Accession
0001209191-20-020747
Insider Transaction Report
Form 4
Levine James E.
Chief Financial Officer
Transactions
- Award
Common Stock
2020-03-19+25,000→ 61,891 total - Exercise/Conversion
Employee Stock Option (right to buy)
2020-03-19+110,000→ 110,000 totalExercise: $1.98Exp: 2030-03-18→ Common Stock (110,000 underlying)
Footnotes (2)
- [F1]On December 3, 2018, the reporting person was granted a performance-based restricted stock unit (RSU) which would vest upon the achievement of various clinical and corporate milestones. On March 19, 2020 the Board accelerated the vesting of the RSU in full.
- [F2]The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 19, 2020.
Documents
Issuer
Cidara Therapeutics, Inc.
CIK 0001610618
Entity typeother
Related Parties
1- filerCIK 0001463151
Filing Metadata
- Form type
- 4
- Filed
- Mar 22, 8:00 PM ET
- Accepted
- Mar 23, 7:16 PM ET
- Size
- 7.5 KB